1. Home
  2. FEAM vs PHGE Comparison

FEAM vs PHGE Comparison

Compare FEAM & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEAM
  • PHGE
  • Stock Information
  • Founded
  • FEAM 2016
  • PHGE 2015
  • Country
  • FEAM United States
  • PHGE Israel
  • Employees
  • FEAM N/A
  • PHGE N/A
  • Industry
  • FEAM Major Chemicals
  • PHGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • FEAM Industrials
  • PHGE Health Care
  • Exchange
  • FEAM Nasdaq
  • PHGE Nasdaq
  • Market Cap
  • FEAM 12.8M
  • PHGE 11.0M
  • IPO Year
  • FEAM N/A
  • PHGE N/A
  • Fundamental
  • Price
  • FEAM $3.51
  • PHGE $0.46
  • Analyst Decision
  • FEAM Strong Buy
  • PHGE Strong Buy
  • Analyst Count
  • FEAM 2
  • PHGE 1
  • Target Price
  • FEAM $121.00
  • PHGE $15.00
  • AVG Volume (30 Days)
  • FEAM 11.9K
  • PHGE 271.1K
  • Earning Date
  • FEAM 05-15-2025
  • PHGE 08-13-2025
  • Dividend Yield
  • FEAM N/A
  • PHGE N/A
  • EPS Growth
  • FEAM N/A
  • PHGE N/A
  • EPS
  • FEAM N/A
  • PHGE N/A
  • Revenue
  • FEAM N/A
  • PHGE N/A
  • Revenue This Year
  • FEAM N/A
  • PHGE N/A
  • Revenue Next Year
  • FEAM N/A
  • PHGE N/A
  • P/E Ratio
  • FEAM N/A
  • PHGE N/A
  • Revenue Growth
  • FEAM N/A
  • PHGE N/A
  • 52 Week Low
  • FEAM $2.82
  • PHGE $0.34
  • 52 Week High
  • FEAM $33.81
  • PHGE $3.86
  • Technical
  • Relative Strength Index (RSI)
  • FEAM 33.46
  • PHGE 44.42
  • Support Level
  • FEAM $3.41
  • PHGE $0.45
  • Resistance Level
  • FEAM $3.85
  • PHGE $0.51
  • Average True Range (ATR)
  • FEAM 0.28
  • PHGE 0.05
  • MACD
  • FEAM -0.06
  • PHGE 0.01
  • Stochastic Oscillator
  • FEAM 15.24
  • PHGE 55.56

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).

Share on Social Networks: